Diabetes Anxiety and Depression Study: A randomised controlled trial of group sessions of cognitive behavioural therapy (CBT) for people with diabetes

INTERVENTION: Diabetic patients whose Hospital Anxiety and Depression Scale (HADS) score indicated anxiety and depression (greater than or equal to 11 on either HADS‐A or HADS‐D or a total of both scores together (HADS‐T) of greater than or equal to 18), were randomised by a computerised randomisation system to either cognitive behavioural therapy (CBT) delivered in group sessions over a six week period or to a control of standard care. Patients whose HADS score did not indicate anxiety or depression continued as an observation group. CONDITION: Diabetes type 1 and 2, anxiety and/or depression ; Nutritional, Metabolic, Endocrine ; Unspecified diabetes mellitus PRIMARY OUTCOME: The difference in glycaemic control 12 months from baseline as measured by HbA1c. SECONDARY OUTCOME: 1. The change in depression and anxiety as measured by HADS 12 months from baseline; 2. The change in quality of life as measured by the 36‐item short form health survey version 2 (SF‐36V2), 12 months from baseline INCLUSION CRITERIA: 1. New diagnosis of diabetes (less than 12 months) 2.18 years of age and above, either sex